Report Overview

Indian Allergy Treatment Market size was valued at USD XX Billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of XX% from 2019 to 2028.

An estimated 300 million people worldwide have asthma, with 379 million in India, equal to 55% of the total UK population. The burden of asthma in India exceeds the number of people with HIV infection or tuberculosis. Within India, there are variations with respect to weather, pollens and fungal spores, insects such as cockroaches, and other living conditions, and meteorological data regarding environmental allergens are sparse These allergens can cause various allergic disease conditions including hay fever or allergic rhinitis, asthma, atopic dermatitis, and others. The major symptoms of allergic reactions include itching in the nose, roof of the mouth, throat, or eyes as well as sneezing, stuffy nose (congestion), teary eyes, and others. In addition, food allergies can cause symptoms such as vomiting, diarrhea, or respiratory symptoms, after ingestion of an allergen. Increased prevalence of allergens and high consumption of tobacco that can induce several allergies drive the growth of the Indian allergy treatment market.



Market Drivers

The rapidly growing heavy environmental pollutants, changing lifestyles, low-quality dietary habits and the existence of a variety of communicable and non-communicable diseases further complicate the prevalence of allergic diseases in India. The major key factors that drive the global allergy treatment market include significant increase in the prevalence of allergic diseases, rise in preferences toward over-the-counter drugs for allergy treatment, and surge in self-medication in consumers. However, increased usage of biosimilars, and safety & efficacy concerns regarding the side effects associated with vigorous consumption of anti-allergy drugs are anticipated to hamper the growth of the allergy treatment market. On the contrary, increased R&D and rise in awareness among healthcare professionals as well as patients regarding immunotherapy for the treatment of allergies are expected to create lucrative opportunities in future.